Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents with clinical and biochemical evidence of hepatocellular injury following the initiation of [Drug Name]. Symptoms include jaundice, right upper quadrant abdominal discomfort, fatigue, and nausea. No history of viral hepatitis, alcohol abuse, or autoimmune liver disease. R-ratio > 5, consistent with hepatocellular pattern.
Clinical Examination Findings
Physical examination reveals scleral icterus and mild hepatomegaly. No stigmata of chronic liver disease (e.g., spider angiomata, palmar erythema, or ascites). Abdominal palpation demonstrates mild tenderness in the right upper quadrant without rebound or guarding. Neurological status is intact, with no signs of hepatic encephalopathy.
Treatment Protocol
Immediate cessation of the suspected offending agent [Drug Name]. Supportive care initiated with close monitoring of liver function tests (LFTs) and coagulation profile. Consider N-acetylcysteine if acetaminophen toxicity is suspected. Avoid hepatotoxic substances, including alcohol and over-the-counter herbal supplements.